Paper39733202
Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway.
Li C and 9 others. J Cardiovasc Transl Res, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway. Papers, record 39733202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39733202
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pyroptosis | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Bufanolides | Major topic |
| Myocytes, Cardiac | Major topic |
| Macrophages | Major topic |
| Sequestosome-1 Protein | Major topic |
| Myocardial Infarction | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Animals | |
| Disease Models, Animal | |
| Signal Transduction | |
| Male | |
| Mice, Inbred C57BL | |
| Mice | |
| RAW 264.7 Cells | |
| Inflammation Mediators | |
| Cytokines |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82230009 | National Natural Science Foundation of China | PubMed | ||
| 82430016 | National Natural Science Foundation of China | PubMed | ||
| 81900245 | National Natural Science Foundation of China | PubMed |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32758258 | Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway. | J Transl Med | 2020 | https://conductscience.org/library/papers/32758258 | PubMed |
| 2 | 25085580 | Bufalin induces cell cycle arrest and apoptosis in gallbladder carcinoma cells. | Tumour Biol | 2014 | https://conductscience.org/library/papers/25085580 | PubMed |
| 3 | 37981501 | Regulated cell death in myocardial ischemia-reperfusion injury. | Trends Endocrinol Metab | 2024 | https://conductscience.org/library/papers/37981501 | PubMed |
| 4 | 30228378 | Cardioimmunology: the immune system in cardiac homeostasis and disease. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/30228378 | PubMed |
| 5 | 32001677 | Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair. | Nat Commun | 2020 | https://conductscience.org/library/papers/32001677 | PubMed |
| 6 | 31036962 | The NLRP3 inflammasome: molecular activation and regulation to therapeutics. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/31036962 | PubMed |
| 7 | 30692261 | Ferroptosis as a target for protection against cardiomyopathy. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30692261 | PubMed |
| 8 | 39224841 | BRD3308 suppresses macrophage oxidative stress and pyroptosis via upregulating acetylation of H3K27 in sepsis-induced acute lung injury. | Burns Trauma | 2024 | https://conductscience.org/library/papers/39224841 | PubMed |
| 9 | 30588824 | p62/SQSTM1 and Selective Autophagy in Cardiometabolic Diseases. | Antioxid Redox Signal | 2019 | https://conductscience.org/library/papers/30588824 | PubMed |
| 10 | 22596221 | Mechanisms of cell death in heart disease. | Arterioscler Thromb Vasc Biol | 2012 | https://conductscience.org/library/papers/22596221 | PubMed |
| 11 | 24515724 | Bufalin, a bioactive component of the Chinese medicine chansu, inhibits inflammation and invasion of human rheumatoid arthritis fibroblast-like synoviocytes. | Inflammation | 2014 | https://conductscience.org/library/papers/24515724 | PubMed |
| 12 | 26982352 | Tissue-Resident Macrophage Ontogeny and Homeostasis. | Immunity | 2016 | https://conductscience.org/library/papers/26982352 | PubMed |
| 13 | 31011289 | New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin. | Cancer Cell Int | 2019 | https://conductscience.org/library/papers/31011289 | PubMed |
| 14 | 29868933 | Mapping macrophage polarization over the myocardial infarction time continuum. | Basic Res Cardiol | 2018 | https://conductscience.org/library/papers/29868933 | PubMed |
| 15 | 12517460 | Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. | Lancet | 2003 | https://conductscience.org/library/papers/12517460 | PubMed |
| 16 | 30168729 | Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. | Am J Physiol Heart Circ Physiol | 2018 | https://conductscience.org/library/papers/30168729 | PubMed |
| 17 | 34015941 | GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury. | Circ Res | 2021 | https://conductscience.org/library/papers/34015941 | PubMed |
| 18 | 33664937 | Myocardial ischemia-reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injury. | J Extracell Vesicles | 2021 | https://conductscience.org/library/papers/33664937 | PubMed |
| 19 | 24786973 | Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. | Circ Res | 2014 | https://conductscience.org/library/papers/24786973 | PubMed |
| 20 | 22138603 | The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. | Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22138603 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41567846 | Pyroptosis in cardiovascular diseases: molecular mechanisms, pathological roles, and therapeutic implications. | Am J Cardiovasc Dis | 2025 | https://conductscience.org/library/papers/41567846 | PubMed |
| 40846852 | Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. | Nat Commun | 2025 | https://conductscience.org/library/papers/40846852 | PubMed |
| 40460555 | Autophagy hub-protein p62 orchestrates oxidative, endoplasmic reticulum stress, and inflammatory responses post-ischemia, exacerbating stroke outcome. | Redox Biol | 2025 | https://conductscience.org/library/papers/40460555 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39733202
GET https://conductscience.org/api/papers/v1/39733202/references?page=2